BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32034172)

  • 1. Assessing diagnostic value of microRNAs from peripheral blood mononuclear cells and extracellular vesicles in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Almenar-Pérez E; Sarría L; Nathanson L; Oltra E
    Sci Rep; 2020 Feb; 10(1):2064. PubMed ID: 32034172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
    Petty RD; McCarthy NE; Le Dieu R; Kerr JR
    PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNAs Expression in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Soffritti I; Gravelsina S; D'Accolti M; Bini F; Mazziga E; Vilmane A; Rasa-Dzelzkaleja S; Nora-Krukle Z; Krumina A; Murovska M; Caselli E
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
    Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
    Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Missailidis D; Sanislav O; Allan CY; Annesley SJ; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of actin network proteins, talin-1 and filamin-A, in circulating extracellular vesicles as blood biomarkers for human myalgic encephalomyelitis/chronic fatigue syndrome.
    Eguchi A; Fukuda S; Kuratsune H; Nojima J; Nakatomi Y; Watanabe Y; Feldstein AE
    Brain Behav Immun; 2020 Feb; 84():106-114. PubMed ID: 31759091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a Blood Cell-Based Diagnostic Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Peripheral Blood Mononuclear Cells.
    Xu J; Lodge T; Kingdon C; Strong JWL; Maclennan J; Lacerda E; Kujawski S; Zalewski P; Huang WE; Morten KJ
    Adv Sci (Weinh); 2023 Oct; 10(30):e2302146. PubMed ID: 37653608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.
    González-Cebrián A; Almenar-Pérez E; Xu J; Yu T; Huang WE; Giménez-Orenga K; Hutchinson S; Lodge T; Nathanson L; Morten KJ; Ferrer A; Oltra E
    Front Med (Lausanne); 2022; 9():842991. PubMed ID: 35433768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments.
    Almenar-Pérez E; Sánchez-Fito T; Ovejero T; Nathanson L; Oltra E
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30889846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients.
    Nguyen T; Johnston S; Chacko A; Gibson D; Cepon J; Smith P; Staines D; Marshall-Gradisnik S
    Asian Pac J Allergy Immunol; 2017 Jun; 35(2):75-81. PubMed ID: 27362406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients.
    Blauensteiner J; Bertinat R; León LE; Riederer M; Sepúlveda N; Westermeier F
    Sci Rep; 2021 May; 11(1):10604. PubMed ID: 34011981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM
    Front Immunol; 2019; 10():796. PubMed ID: 31057538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Fenouillet E; Vigouroux A; Steinberg JG; Chagvardieff A; Retornaz F; Guieu R; Jammes Y
    J Transl Med; 2016 Aug; 14(1):251. PubMed ID: 27580693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Long-Term Cryopreservation on Blood Immune Cell Markers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Biomarker Discovery.
    Gómez-Mora E; Carrillo J; Urrea V; Rigau J; Alegre J; Cabrera C; Oltra E; Castro-Marrero J; Blanco J
    Front Immunol; 2020; 11():582330. PubMed ID: 33329554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Esfandyarpour R; Kashi A; Nemat-Gorgani M; Wilhelmy J; Davis RW
    Proc Natl Acad Sci U S A; 2019 May; 116(21):10250-10257. PubMed ID: 31036648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic lymphocyte microRNAs as prospective biomarkers for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
    Brenu EW; Ashton KJ; van Driel M; Staines DR; Peterson D; Atkinson GM; Marshall-Gradisnik SM
    J Affect Disord; 2012 Dec; 141(2-3):261-9. PubMed ID: 22572093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput sequencing of plasma microRNA in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; Ashton KJ; Batovska J; Staines DR; Marshall-Gradisnik SM
    PLoS One; 2014; 9(9):e102783. PubMed ID: 25238588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.